About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6604 record(s)
Req # A-2020-000460
Adverse Drug Reaction (ADR) for botulinum toxin brand name. Report number: E2B_03068655.Organization: Health Canada
February 2021
Req # A-2020-000539
Adverse Reaction Reports (AERs) for INSULIN GLARGINE. Report numbers: 730858, 732799, 733584, 734304.Organization: Health Canada
February 2021
Req # A-2020-000546
Adverse Reaction Reports (AERs) for TERIFLUNOMIDE. Report numbers: 735570, E2B_02848292, E2B_02921071.Organization: Health Canada
February 2021
Req # A-2020-000660
Adverse Reaction Reports (AERs) for DEXILANT. Report numbers: E2B_03122964, E2B_03123449, E2B_03106078.Organization: Health Canada
February 2021
Req # A-2020-000663
Adverse Reaction Reports (AERs) for VEDOLIZUMAB. Report numbers: E2B_03058557, E2B_03105558, E2B_03108821, E2B_03109369, E2B_03114409, E2B_03114936. E2B_03124462, E2B_03138211, E2B_03149549, E2B_03152074, E2B_03153521, E2B_03156764, E2B_03157176,…Organization: Health Canada
February 2021
Req # A-2020-000712
Adverse Reaction Reports (AERs). Report numbers: E2B_02637979, E2B_02691221, 000733603, E2B_02722938, E2B_02775548, E2B_02879844, E2B_02899406, E2B_02899423, E2B_02928723, E2B_02931031.Organization: Health Canada
February 2021
Req # A-2020-000780
Adverse Reaction Reports (AERs). Report numbers: E2B_03005325, E2B_03170719, E2B_03170942, 000914300, E2B_02785989, 000914302 000915863.Organization: Health Canada
February 2021
Req # A-2020-000809
Adverse Reaction Reports (AERs). Report numbers: E2B_02956696, E2B_02956422, E2B_02984209, E2B_02996660, E2B_03045680, E2B_03047613.Organization: Health Canada
February 2021
Req # A-2020-000826
Adverse Drug Reaction (ADR). Report number: E2B_03233229.Organization: Health Canada
February 2021
Req # A-2020-000827
Adverse Drug Reaction (ADR) for Propiverine (MICTORYL): E2B_03204835.Organization: Health Canada
February 2021